|
|
|
Press Releases
|
|
 = Add Release to Briefcase |
| All Releases |
|---|
 |
SenoRx Reports 37.7 Percent Growth in Second Quarter 2008 Revenue; Gross Margins Increase to 61.3 Percent From 57.0 Percent a Year Ago
Aug 11, 2008
|
32.2 KB
|
| |
ALISO VIEJO, Calif., Aug 11, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its second quarter ended June 30, 2008. Revenue for the quarter increased 37.7 percent to $11.2 million, compared with $8.1 million in the second quarter a year ago. Gross profit increased 48.1 percent to $6.9...
|
|
|
SenoRx to Present At the 28th Annual Canaccord Adams Global Growth Conference
Jul 29, 2008
|
20.7 KB
|
| |
ALISO VIEJO, Calif., Jul 29, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the 28th Annual Canaccord Adams Global Growth Conference on Thursday, August 14, 2008 at the InterContinental Boston Hotel, in Boston, Massachusetts. The c...
|
|
|
SenoRx Announces Second Quarter 2008 Webcast and Conference Call
Jul 10, 2008
|
21.1 KB
|
| |
ALISO VIEJO, Calif., Jul 10, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host a conference call to review its second quarter 2008 financial results on Tuesday, August 12 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). The call will be open to all investors live via the Investor Relations se...
|
|
|
SenoRx Receives Additional 510(k) Clearance for Its Contura MLB
Jul 1, 2008
|
22.7 KB
|
| |
ALISO VIEJO, Calif., Jul 1, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a second Contura(tm) MLB short-term breast radiation balloon design.
"The novel proprietary design of our newest Contura Multi-Lumen Rad...
|
|
|
SenoRx Announces Court Grants Jointly Requested Stay of Proceedings
Jun 24, 2008
|
19.9 KB
|
| |
ALISO VIEJO, Calif., Jun 24, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx (Nasdaq:SENO) today announced that the United States District Court for the Northern District of California has granted a joint request by Hologic and SenoRx to stay all proceedings in the case currently pending between the parties, including the Markman claims cons...
|
|
|
SenoRx Appoints A. Thomas Bender to Board of Directors
Jun 6, 2008
|
20.8 KB
|
| |
ALISO VIEJO, Calif., Jun 6, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx (Nasdaq:SENO) today announced the appointment of A. Thomas Bender to its board of directors, effective June 5, 2008. Mr. Bender is currently Chairman of the Board of The Cooper Companies, Inc., a position he has held since 2002. He served as President and Chief Execu...
|
|
|
SenoRx to Present At Needham 7th Annual Biotechnology and Medical Technology Conference
Jun 2, 2008
|
20.7 KB
|
| |
ALISO VIEJO, Calif., Jun 2, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the Needham 7th Annual Biotechnology and Medical Technology Conference on Thursday, June 12, 2008 at the New York Palace Hotel, New York, New York. The comp...
|
|
|
SenoRx Announces Court Dismisses Unfair Competition and False Advertising Claims
May 27, 2008
|
20.4 KB
|
| |
ALISO VIEJO, Calif., May 27, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO), a company that manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, today announced that the District Court issued an order relating to the lawsuit filed by H...
|
|
|
SenoRx Reports First Quarter 2008 Revenue Grows 38.7 Percent; Gross Margin Increases to 62.1 Percent From 54.1 Percent a Year Ago
May 12, 2008
|
30.8 KB
|
| |
ALISO VIEJO, Calif., May 12, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2008. Revenue for the quarter increased 38.7 percent to $10.7 million, compared with $7.7 million in the first quarter a year ago. Gross profit increased 59.3 percent to $6.6 ...
|
|
|
SenoRx to Present at Two Investor Conferences in May
May 7, 2008
|
20.4 KB
|
| |
ALISO VIEJO, Calif., May 7, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will be presenting at the following conferences:
Bank of America 2008 Healthcare Conference
The Four Seasons, Las Vegas, Nevada
Thursday, May 15,...
|
|
|
SenoRx Appoints John Buhler as Vice President of International Sales and Business Development
May 6, 2008
|
22.4 KB
|
| |
ALISO VIEJO, Calif., May 6, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced the appointment of John T. Buhler as Vice President of International Sales and Business Development. Most recently, Buhler served as President and Chief Executive Officer of Ultrasonix Medical Corporation, a privately held company ...
|
|
|
SenoRx Receives Clearance for Modification to Its Contura MLB Product Warning Label
May 5, 2008
|
22.9 KB
|
| |
ALISO VIEJO, Calif., May 5, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received clearance to modify a warning on its Contura(tm) Multi-Lumen Radiation Balloon (MLB) Catheter product label from the U.S. Food and Drug Administration. The revised warning clarifies the use of the Contura MLB i...
|
|
|
Court Denies Hologic Request for Preliminary Injunction Against Sales of Contura
Apr 29, 2008
|
20.3 KB
|
| |
ALISO VIEJO, Calif., Apr 29, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that a request for a preliminary injunction, filed by Hologic and its wholly-owned subsidiaries, Cytyc Corporation and Cytyc LP in their pending patent infringement suit against SenoRx, Inc., was denied by the United States Distri...
|
|
|
SenoRx Announces First Quarter 2008 Financial Results Conference Call
Apr 15, 2008
|
20.9 KB
|
| |
ALISO VIEJO, Calif., Apr 15, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its first quarter 2008 financial results on Tuesday, May 13, 2008 prior to the market open. A conference call to review the results will follow at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). This call will be ...
|
|
|
SenoRx Announces CE Mark Approval for Its SenoSonix With EnCor Breast Biopsy Ultrasound System
Apr 10, 2008
|
23.4 KB
|
| |
ALISO VIEJO, Calif., Apr 10, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received approval to apply the CE Mark to its SenoSonix(tm) with EnCor, an integration of its EnCor(r) breast biopsy system with a state-of-the-art ultrasound imaging system. The device incorporates SenoRx's proprietar...
|
|
|
SenoRx Launches Products in Additional Countries
Apr 3, 2008
|
20.8 KB
|
| |
ALISO VIEJO, Calif., Apr 3, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has launched EnCor(r), its flagship vacuum-assisted breast biopsy product, and its line of breast biopsy tissue markers in additional countries outside the U.S. SenoRx products will now also be marketed through distributors...
|
|
|
SenoRx Announces Participation in Upcoming Investor Conferences
Mar 6, 2008
|
20.6 KB
|
| |
ALISO VIEJO, Calif., Mar 6, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will be presenting at the following conferences:
Cowen and Company 28th Annual Health Care Conference
The Boston Marriott Copley Place, Boston, MA
Tuesday...
|
|
|
SenoRx Reports Revenue Growth of 43.2 Percent in Q4 2007 Compared With Q4 2006
Feb 19, 2008
|
31.2 KB
|
| |
ALISO VIEJO, Calif., Feb 19, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its fourth quarter and year ended December 31, 2007. Revenue for the quarter increased 43.2 percent to $10.3 million, compared with $7.2 million in the fourth quarter of 2006. Full-year revenue in 2007 grew 37...
|
|
|
SenoRx Announces Fourth Quarter and Full-Year 2007 Financial Results Conference Call
Feb 1, 2008
|
21.0 KB
|
| |
ALISO VIEJO, Calif., Feb 1, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its fourth quarter and full-year 2007 financial results on Tuesday, February 19, 2008 prior to the market open. A conference call to review the results will follow at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time)....
|
|
|
SenoRx Launches Contura MLB
Jan 17, 2008
|
22.5 KB
|
| |
ALISO VIEJO, Calif., Jan 17, 2008 (PrimeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has launched Contura(tm), its Multi-Lumen Balloon (MLB) Catheter for delivering brachytherapy to the surgical margins following lumpectomy for breast cancer. The company had previously said that it intended to transition f...
|
|
|
|
Stock Information
SENO - (NASD)
$6.04
- 0.04
|
Aug 20, 2008
4:00 PM ET |
Quotes delayed at least 20 minutes.
Information provided by TurboFeed.
|
